Anebulo Pharmaceuticals (ANEB) Treasury Shares (2020 - 2021)
Anebulo Pharmaceuticals (ANEB) posted quarterly Treasury Shares of $2.0 million for Q1 2021, little changed quarter-over-quarter from $2.0 million in Q2 2020.
Anebulo Pharmaceuticals (ANEB) Treasury Shares (2020 - 2021) Analysis & Trends
Anebulo Pharmaceuticals (ANEB) has reported Treasury Shares for 2 consecutive years, with $2.0 million the latest figure, recorded in Q1 2021.
- In Q1 2021, Treasury Shares changed N/A year-over-year to $2.0 million; the TTM figure through Mar 2021 stood at $2.0 million (changed N/A YoY), while the FY2020 annual figure was $2.0 million, changed N/A from the prior year.
- Treasury Shares was little changed at $2.0 million in Q1 2021 per ANEB's latest filing, from $2.0 million in the prior quarter.
- Across five years, Treasury Shares topped out at $2.0 million in Q2 2020 and bottomed at $2.0 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.72 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 8.96 Mn |
| 10 | Anebulo Pharmaceuticals | 16.43 Mn | 16.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 2.05 Mn |
| Mar 31, 2021 | 2.05 Mn |
| Jun 30, 2020 | 2.05 Mn |
| Jun 30, 2020 | 2.05 Mn |